Browse > Article
http://dx.doi.org/10.4062/biomolther.2014.148

The Inhibitory Effect of Shikonin on the Agonist-Induced Regulation of Vascular Contractility  

Je, Hyun Dong (Department of Pharmacology, College of Pharmacy, Catholic University of Daegu)
Kim, Hyeong-Dong (Department of Physical Therapy, College of Health Science, Korea University)
La, Hyen-Oh (Department of Pharmacology, College of Medicine, The Catholic University of Korea)
Publication Information
Biomolecules & Therapeutics / v.23, no.3, 2015 , pp. 233-237 More about this Journal
Abstract
Shikonin, a natural flavonoid found in the roots of Lithospermum erythrorhizon, has been shown to possess many biological functions. The present study was undertaken to investigate the influence of shikonin on vascular smooth muscle contractility and to determine the mechanism involved. Denuded aortic rings from male rats were used and isometric contractions were recorded and combined with molecular experiments. Shikonin significantly relaxed fluoride-, thromboxane $A_2$- or phorbol ester-induced vascular contraction suggesting as a possible anti-hypertensive on the agonist-induced vascular contraction regardless of endothelial nitric oxide synthesis. Furthermore, shikonin significantly inhibited fluoride-induced increases in pMYPT1 levels and phorbol ester-induced increases in pERK1/2 levels suggesting the mechanism involving the inhibition of Rho-kinase activity and the subsequent phosphorylation of MYPT1 and the inhibition of MEK activity and the subsequent phosphorylation of ERK1/2. This study provides evidence regarding the mechanism underlying the relaxation effect of shikonin on agonist-induced vascular contraction regardless of endothelial function.
Keywords
ERK1/2; Fluoride; MYPT1; Phorbol ester; Rho-kinase; Shikonin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Andujar, I., Rios, J. L., Giner, R. M. and Recio, M. C. (2013) Pharmacological properties of shikonin-A review of literature since 2002. Planta Med. 79, 1685-1697.   DOI
2 Chang, I. C., Huang, Y. J., Chiang, T. I., Yeh, C. W. and Hsu, L. S. (2010) Shikonin induces apoptosis through reactive oxygen species extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol. Pharm. Bull. 33, 816-824..   DOI
3 Chen, X., Yang, L., Oppenheim, J. J. and Howard, O. M. Z. (2002) Cellular pharmacology studies of shikonin derivatives. Phytother. Res. 16, 199-209.   DOI
4 Gu, Z., Kordowska, J., Williams, G. L., Wang, C. L. and Hai, C. M. (2007) Erk1/2 MAPK and caldesmon differentially regulate podosome dynamics in A7r5 vascular smooth muscle cells. Exp. Cell Res. 313, 849-866.   DOI
5 Han, W., Li, L., Qiu, S., Lu, Q., Pan, Q., Gu, Y., Luo, J. and Hu, X. (2007) Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther. 6, 1641-1649.   DOI   ScienceOn
6 Hu, C. M., Cheng, Y. W., Cheng, H. W., and Kang, J. J. (2004) Impairment of vascular function of rat thoracic aorta in an endotheliumdependent manner by shikonin/alkannin and derivatives isolated from roots of Macrotomia euchroma. Planta Med. 70, 23-28.   DOI
7 Jeon, S. B., Jin, F., Kim, J. I., Kim, S. H., Suk, K., Chae, S. C., Jun, J. E., Park, W. H. and Kim, I. K. (2006) A role for Rho kinase in vascular contraction evoked by sodium fluoride. Biochem. Biophys. Res. Commun. 343, 27-33.   DOI
8 Kitazawa, T., Masuo, M. and Somlyo, A. P. (1991) G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 88, 9307-9310.   DOI
9 Kordowska, J., Huang, R. and Wang, C. L. (2006) Phosphorylation of caldesmon during smooth muscle contraction and cell migration or proliferation. J. Biomed. Sci. 13, 159-172.   DOI
10 Lu, L., Qin, A., Huang, H., Zhou, P., Zhang, C., Liu, N., Li, S., Wen, G., Zhang, C., Dong, W., Wang, X., Dou, Q. P. 0 and Liu, J. (2011) Shikonin extracted from medicinal chinese herbs exerts anti-inflammatory effect via proteasome inhibition. Eur. J. Pharmacol. 658, 242-247.   DOI
11 Muranyi, A., MacDonald, J. A., Deng, J. T., Wilson, D. P., Haystead, T. A., Wlash, M. P., Erdodi, F., Kiss, E., Wu, Y. and Hartshorne, D. J. (2002) Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem. J. 366, 211-216.   DOI
12 Sakurada, S., Takuwa, N., Sugimoto, N., Wang, Y., Seto, M., Sasaki, Y. and Takuwa, Y. (2003) $Ca^{2+}$-dependent activation of Rho and Rhokinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ. Res. 93, 548-556.   DOI
13 Tsai, M. H. and Jiang, M. J. (2006) Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction. Pflugers Arch. 453, 223-232.   DOI
14 Somlyo, A. P. and Somlyo, A. V. (1994) Signal transduction and regulation in smooth muscle. Nature 372, 231-236.   DOI
15 Somlyo, A. P. and Somlyo, A. V. (1998) From pharmacomechanical coupling to G-proteins and myosin phosphatase. Acta Physiol. Scand. 164, 437-448.   DOI
16 Touyz, R. M., Deng, L. Y., He, G., Wu, X. H. and Schiffrin, E. L. (1999) Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J. Hypertens. 17, 907-916.   DOI
17 Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. and Narumiya, S. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.   DOI
18 Wang, Y., Zhou, Y., Jia, G., Han, B., Liu, J., Teng, Y., Lv, J., Song, Z., Li, Y., Ji, L., Pan, S., Jiang, H. and Sun, B. (2014) Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-${\kappa}B$ signaling pathway. Biochem. Pharmacol. 88, 322-333.   DOI   ScienceOn
19 Wier, W. G. and Morgan, K. G. (2003) ${\alpha}1$-Adrenergic signaling mechanisms in contraction of resistance arteries. Rev. Physiol. Biochem. Pharmacol. 150, 91-139.
20 Wilson, D. P., Susnjar, M., Kiss, E., Sutherland, C. and Walsh, M. P. (2005) Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of $Ca^{2+}$ entry and $Ca^{2+}$ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem. J. 389, 763-774.   DOI
21 Wooldridge, A. A., MacDonald, J. A., Erdodi, F., Ma, C., Borman, M. A., Hartshorne, D. J. and Haystead, T. A. (2004) Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. J. Biol. Chem. 279, 34496-34504.   DOI
22 Xu, Q., Liu, Y., Gorospe, M., Udelsman, R. and Holbrook, N. J. (1996) Acute hypertension activates mitogen-activated protein kinases in arterial wall. J. Clin. Invest. 97, 508-514.   DOI